News for Viatris Inc. (VIA.DE)

We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are going to take a look at where Viatris Inc.

PR NewswireNEW YORK, March 3, 2025 NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Viatris Inc. ("V

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where Viatris Inc.

We recently compiled a list of the 10 Stocks Drop by Double Digits Mostly Due to Disappointing Earnings. In this article, we are going to take a look at where Viatris Inc.

Total Revenue: $14.7 billion for 2024, up 2% year over year.Adjusted EBITDA: Approximately $4.7 billion for 2024.Adjusted EPS: $2.65 per share for 2024.Free Ca

Feb 27, 2025 / 01:30PM GMTOperator Good morning, everyone, and welcome to the Viatris Q4 and full year 2024 earnings call. (Operator Instructions) Please also n

**media[552929]**

Viatris Inc. (NASDAQ:VTRS) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ETCompany ParticipantsBill Szablewski - Head of Capital MarketsScott...

Viatris Inc. missed sales/EPS estimates with 2025 guidance showing challenges like a $385M EBITDA hit. Learn why experts suggest avoiding VTRS stock.

The following slide deck was published by Viatris Inc.

Quarterly Revenue: $3.52 billion, missing the estimated $3.61 billion.Quarterly EPS: Adjusted EPS of $0.54, above the estimated $0.28.Annual Revenue: $14.7 bil

Summary On February 27, 2025, Viatris Inc (VTRS) announced its 2025 dividend policy, which includes a total annual dividend of 48 cents per share. The Board of

PR NewswirePITTSBURGH, Feb. 27, 2025 PITTSBURGH, Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on February 24, 2025, its B

PR NewswireDUBLIN, Feb. 26, 2025 YUPELRI® (revefenacin) US net sales, recognized by Viatris, reached an all-time high of $66.7 million in Q4 2024 and $238

**media[550416]**

Long-established in the Drug Manufacturers industry, Viatris Inc (VTRS) has enjoyed a stellar reputation. It has recently witnessed a daily gain of 0.22%, juxta

On February 17, 2025, Viatris Inc (VTRS) released a press statement celebrating the remarkable 50-year career of Leo, a dedicated employee who has been instrume

Insightful Moves in the Fourth Quarter of 2024 Kahn Brothers (Trades, Portfolio) recently submitted their 13F filing for the fourth quarter of 2024, offering a

On December 31, 2024, Camber Capital Management LLC (Trades, Portfolio) executed a significant transaction by acquiring 2,722,987 shares of ZimVie Inc at a trad